You can buy or sell BioMarin and other stocks, options, ETFs, and crypto commission-free!
BioMarin Pharmaceutical Inc. Common Stock, also called BioMarin, is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Read More Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA. The listed name for BMRN is BioMarin Pharmaceutical Inc. Common Stock.
San Rafael, California
52 Week High
52 Week Low
BioMarin, Pioneer in Phenylketonuria and Gene Therapy, Doses First Participant in Global PHEARLESS Phase 1/2 Study of BMN 307 Gene Therapy
SAN RAFAEL, Calif., Sept. 24, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that it has dosed the first participant in the glo
— per share
Expected Oct 21, After Hours